Memory Pharmaceuticals' Series B Round

Memory Pharmaceuticals raised a round of funding on April 01, 2000.

Memory Pharmaceuticals Corp., a publicly traded biopharmaceutical company, focuses on developing drugs for the treatment of CNS disorders such as Alzheimer's disease, schizophrenia, depression and bip…

Articles about Memory Pharmaceuticals' Series B Round: